NCT05791994 · RECRUITING
EVASION: Effect of VisuAl Stimulation on attentION
This trial is testing whether a visual brain-training software called Emeraude helps people with a specific type of mild cognitive impairment — the kind that affects planning and mental flexibility — process information faster. Participants either do daily visual cognitive exercises or watch TV for 30 days. Researchers also track memory, walking ability, and quality of life. This is a Phase NA trial, meaning it is more of a structured feasibility or exploratory study than a large efficacy trial.
You may qualify if
- Age ≥ 60 years
- Diagnosis of mild cognitive impairment of a dysexecutive or multidomain dysexecutive nature, according to Winblad consensus criteria
- Presence of an informal caregiver
- Subject gave and signed informed consent to participate in the study
- Affiliation to a social security scheme
You're excluded if
- Presence of severe depressive symptoms (4-item Geriatric Depression Scale score > 2)
- Ophthalmological or central pathology that may affect the performance of stimulation exercises
- Regular use of psychotropic drugs that may have an impact on the performance of stimulation exercises, in the opinion of the investigator (benzodiazepines, antidepressants, neuroleptics, hypnotics)
- Use of anticonvulsant drugs
- Existence of a confusional syndrome
- Participation in another simultaneous clinical trial
- Person deprived of liberty by judicial or administrative decision
- Person under forced psychiatric care
- Person subject to a legal protection measure
- Person unable to give consent
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-04-06